Magnetar Financial LLC Acquires 6,933 Shares of Encompass Health Corporation $EHC

Magnetar Financial LLC grew its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 107.4% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,391 shares of the company’s stock after buying an additional 6,933 shares during the period. Magnetar Financial LLC’s holdings in Encompass Health were worth $1,642,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Congress Asset Management Co. bought a new position in Encompass Health during the second quarter worth $92,691,000. Nuveen LLC acquired a new position in shares of Encompass Health during the first quarter valued at about $50,665,000. T. Rowe Price Investment Management Inc. raised its holdings in shares of Encompass Health by 25.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock valued at $210,756,000 after purchasing an additional 424,691 shares during the period. Strs Ohio bought a new position in shares of Encompass Health during the 1st quarter worth about $34,364,000. Finally, American Century Companies Inc. grew its stake in shares of Encompass Health by 78.6% in the 1st quarter. American Century Companies Inc. now owns 723,169 shares of the company’s stock valued at $73,243,000 after buying an additional 318,251 shares during the period. Institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Up 1.5%

Shares of Encompass Health stock opened at $114.44 on Friday. The company has a market capitalization of $11.51 billion, a P/E ratio of 21.63, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. The stock has a fifty day simple moving average of $121.34 and a 200 day simple moving average of $119.56. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $127.99. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The firm had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, sell-side analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 14.37%.

Analyst Ratings Changes

Several research analysts have issued reports on EHC shares. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Truist Financial upped their target price on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research report on Thursday, August 14th. Barclays lifted their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday. Finally, Zacks Research cut shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $142.86.

Insider Activity at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares of the company’s stock, valued at $2,329,177.14. This trade represents a 5.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.